DRKS00005368已完成不适用
Characterisation of lipoproteins from patients with preeclampsia compared to healthy, pregnant and healthy, non-pregnant women
niversitätklinikum Freiburg Institut für Klinische Chemie und Laboratoriumsmedizin0 个研究点目标入组 155 人开始时间: 2013年11月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 155
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- Female
入选标准
- •Group 1 (case): Pregnant women with preeclampsia according to the criteria of the German Society of Gynaecology and Obstetrics: hyptertension in pregancy (RR>140/90mmHg) and proteinuria (>300 mg/24h) occuring after the 20th week of pregnancy. Preeclampsia can also be diagnosed without proteinuria if fetal growth restriction, liver involvement, renal insufficiency, neurological dysfunctions or hematological disorders are observed after the 20th week of pregnancy. Informed consent. Age >18 years. Group 2 (control): for every individual from group 1 a healthy, pregnant women in matching gestational age (+/- 1 week). Informed consent. Age > 18 years. Group 3 (control): Healthy, non pregnant women. Informed consent. Age > 18 years and < 45 years.
排除标准
- •Group 1 (case): lack of informed consent. Group 2 and 3 (controls): lack of informed consent. By anamnesis detection of: arterial hypertension, treatment with antihypertensive agents and other cardiac drugs, diabetes mellitus, renal insufficiency, lipid disorders, liver diseases.
研究者
相似试验
进行中（未招募）
不适用
Modeling of lipoprotein in patients with familial hypercholesterolemia compared to healthy subjectsE78.0Pure hypercholesterolaemiaDRKS00007125niversitätsklinikum Freiburg Institut für klinische Chemie und Laboratoriumsmedizin12
进行中（未招募）
1 期
mathematical modelling of the fat metabolism in healthy subjects and patients suffering the desease familial hypercholesterolemiafamilial hypercholesterolemiaEUCTR2014-005473-36-DEniversitätsklinikum Freiburg12
进行中（未招募）
1 期
Characterization of lipid changes in patients with ulcerative colitis treated with tofactinib or infliximabEUCTR2018-004587-61-NLErasmus Medical Center40
尚未招募
不适用
ipid changes in patients with active ulcerative colitis treated with either tofacitinib or infliximabNL-OMON23533Erasmus Medical Center40
已完成
4 期
Deep profiling of lipid changes in patients with active ulcerative colitis treated with either tofacitinib or infliximabulcerative colitisinflammatory bowel disease1001796910003816NL-OMON55536Erasmus MC, Universitair Medisch Centrum Rotterdam40